Nu Skin Enterprises, Inc. (NUS) is likely to register a decline in top and bottom lines when it reports third-quarter 2024 earnings on Nov. 7. The Zacks Consensus Estimate for revenues is pegged at $444.1 million, suggesting a decrease of nearly 11% from the prior-year quarter’s reported figure. The consensus mark for earnings has remained unchanged in the past 30 days at 20 cents per share, indicating a decline of 64.3% from the figure reported in the year-ago quarter. NUS has a trailing four-quarter earni ...